방법론 색인 — 어떤 분석을 어떤 논문이 썼나 🆕 최근 업데이트
이 논문의 관계도
List view
Current PaperMethodsOverviews · Radiology
Neoadjuvant / Perioperative Immunotherapy연결 근거: neoadjuvant, perioperative, resectable, surgical attrition, pathologic response
- ReviewClinical Oncology 종합 리뷰연결어: neoadjuvant, perioperative, resectable
- Statistics통계 방법론 리뷰연결어: neoadjuvant, perioperative, resectable
- Yang 2024Treatment patterns and clinical outcomes of patients with resectable non-small cell lung cancer…연결어: neoadjuvant, perioperative, resectable
- Bang 2025Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase…연결어: neoadjuvant, perioperative, pathologic response
- Forde 2025Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer연결어: neoadjuvant, perioperative, resectable
- +44 more
Immunotherapy Response and Resistance연결 근거: pseudoprogression, acquired resistance, progressive disease, radiologic progression, immune checkpoint inhibitors
- ReviewClinical Oncology 종합 리뷰연결어: pseudoprogression, dissociated response, acquired resistance
- Masse 2024[18F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patie…연결어: pseudoprogression, dissociated response, immune checkpoint inhibitors
- Wang 2022Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict c…연결어: progressive disease, immune checkpoint inhibitors, pembrolizumab
- ReviewBiomedical Imaging 종합 리뷰연결어: progressive disease, immune checkpoint inhibitors, pembrolizumab
- Statistics통계 방법론 리뷰연결어: progressive disease, immune checkpoint inhibitors, pembrolizumab
- +36 more
Extranodal Extension Imaging연결 근거: extranodal extension, nodal
- Henson 2024Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and…연결어: extranodal extension, ene, nodal
- Jang 2023Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung…연결어: extranodal extension, ene, nodal
- Jang 2023Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung…연결어: extranodal extension, ene, nodal
- Chohan 2025Pathological extranodal extension in head and neck cancer: A prognostic biomarker with therapeu…연결어: extranodal extension, ene, nodal
- ReviewBiomedical Imaging 종합 리뷰연결어: extranodal extension, ene, nodal
- +8 more
Radiomics and Radiogenomics연결 근거: radiomics, radiomic, radiogenomic, intratumor heterogeneity, subsampling
- ReviewBiomedical Imaging 종합 리뷰연결어: radiomics, radiomic, radiogenomic
- Statistics통계 방법론 리뷰연결어: radiomics, radiomic, radiogenomic
- Su 2023Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and t…연결어: radiomics, radiomic, radiogenomic
- Henry 2022Investigation of radiomics based intra-patient inter-tumor heterogeneity and the impact of tumo…연결어: radiomics, radiomic, subsampling
- Song 2017Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma연결어: radiomics, radiomic
- +21 more
Thoracic CT / PET Imaging연결 근거: ct, pet, pulmonary, lung transplantation, churg-strauss
- ReviewClinical Pulmonology 종합 리뷰연결어: ct, pet, pulmonary
- Statistics통계 방법론 리뷰연결어: ct, pet, pulmonary
- DeFreitas 2021Complications of Lung Transplantation: Update on Imaging Manifestations and Management연결어: ct, pet, pulmonary
- Cottin 2016Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)연결어: ct, pulmonary, egpa
- ReviewBiomedical Imaging 종합 리뷰연결어: ct, pet, pulmonary
- +64 more
Shared Tags이 논문의 tags: adjuvant, durvalumab, neoadjuvant, nivolumab, pembrolizumab
- Liu 2024Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treat…공유 tag: adjuvant, durvalumab, neoadjuvant, nivolumab
- Sorin 2024Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis공유 tag: adjuvant, durvalumab, neoadjuvant, nivolumab
- Statistics통계 방법론 리뷰공유 tag: adjuvant, durvalumab, neoadjuvant, nivolumab
- Qu 2024Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in l…공유 tag: adjuvant, neoadjuvant, nivolumab, pembrolizumab
- Xiong 2025Delta-radiomics features combined with haematological index predict pathological complete respo…공유 tag: adjuvant, durvalumab, neoadjuvant, nivolumab
- +66 more
라이브러리 148편을 스캔해, 각 통계·방법론을 실제로 사용한 논문을 모았습니다. 실험을 설계할 때 "이 방법을 쓴 선례가 내 라이브러리에 뭐가 있지?"를 바로 찾을 수 있습니다. 각 방법의 자세한 해설은 통계 방법론 리뷰에 있습니다.
> 탐지는 방법명 패턴 매칭입니다(통계 방법론 리뷰와 동일 기준). 본문의 ## 통계 분석·## 방법과 제목·요약에서 찾으므로, 언급이 없으면 누락될 수 있습니다.
생존분석
Kaplan-Meier 생존곡선 (57편)
- Sublobar resection, stereotactic body radiotherapy, and thermal ablation for early-stage non-small cell lung cancer a systematic review and meta-analysis — Lung Cancer · 2026
- Lee et al. - Lung Cancer 2026 - Surgical Attrition After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer: Real-World Experience and Predictors — Lung Cancer · 2026
- Interpretable multimodal deep learning for time-resolved survival prediction after hepatocellular carcinoma resection — npj Digital Medicine · 2026
- Genomic Profiling, Risk Stratification, and Post-Transformation Treatment — 2026
- Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology — Journal of the National Comprehensive Cancer Network · 2026
- Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC A Real-World Analysis Using a Nationwide Claims Database in Japan — 2026
- Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC A Real-World Analysis Using a Nationwide Claims Database in Japan — 2026
- Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study — Lung Cancer · 2025
- The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types — Nature Cancer · 2025
- Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 Trial — Journal of Thoracic Oncology · 2025
- Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer — Lung Cancer · 2025
- Real-world outcomes of subsequent treatment strategies after durvalumab consolidation in stage III unresectable non-small cell lung cancer — 2025
- Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer — New England Journal of Medicine · 2025
- Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC — Clinical Cancer Research · 2025
- Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy — JAMA Oncology · 2025
- Association between pathologic response and survival after neoadjuvant therapy in lung cancer — Nature Medicine · 2024
- Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer — 2024
- Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB–IIIB lung squamous cell carcinoma — Scientific Reports · 2024
- [[clinical-oncology/masse-2024-18f-fdg-petct-atypical-response-patterns-to|[18F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management proposal]] — European Journal of Nuclear Medicine and Molecular Imaging · 2024
- Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non–Small Cell Lung Cancer — 2024
- Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study — BMC Medicine · 2024
- Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis — JAMA Oncology · 2024
- Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer — 2024
- Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World) — The Journal of Thoracic and Cardiovascular Surgery · 2024
- Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets — Science Advances · 2023
- Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study — JTO Clinical and Research Reports · 2023
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non–Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer — Cancer · 2023
- Brief Report Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC A Post Hoc Subgroup Analysis From PACIFIC — 2023
- Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy PACIFIC-KR — 2023
- Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer — 2023
- Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial — The Annals of Thoracic Surgery · 2023
- Chemo-Radio-Immunotherapy for NSCLC III ESRATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate — 2023
- Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer — Frontiers in Oncology · 2023
- Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer — Acta Oncologica · 2022
- 2405-6308/© 2022 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. This is an open access article under the — 2022
- Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer — Journal of Clinical Oncology · 2022
- Five-Year Survival Outcomes From the PACIFIC Trial Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer — 2022
- Disclosure: Dr. Girard reports receiving research grants/support from — 2022
- Imaging the acute respiratory distress syndrome: past, present and future — Intensive Care Med · 2022
- Are radiomics features universally applicable to different organs? — Cancer Imaging · 2021
- Deep Learning to Estimate Biological Age From Chest Radiographs — JACC Cardiovascular Imaging · 2021
- The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition — Annals of Oncology · 2021
- Lesion-level heterogeneity of radiologic progression in patients treated with pembrolizumab — Annals of Oncology · 2021
- Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker — Journal for Immunotherapy of Cancer · 2020
- PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma — Cancer Management and Research · 2020
- Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer — 2020
- Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial — 2020
- Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer — New England Journal of Medicine · 2018
- Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma — Journal of Thoracic Oncology · 2017
- Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma — npj Genomic Medicine · 2017
- Pulmonary Intravascular Lymphomatosis: Clinical, CT, and PET Findings, Correlation of CT and Pathologic Results, and Survival Outcome — Radiology · 2016
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer — Journal of Thoracic Oncology · 2016
- Introduction to the Analysis of Survival Data in the Presence of Competing Risks — 2016
- Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings — European Radiology · 2007
- park-2026-quantitative-ct-imaging-in-progressive-pulmonary-fibrosis
Cox proportional hazards model (64편)
- Lee et al. - Lung Cancer 2026 - Surgical Attrition After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer: Real-World Experience and Predictors — Lung Cancer · 2026
- Interpretable multimodal deep learning for time-resolved survival prediction after hepatocellular carcinoma resection — npj Digital Medicine · 2026
- Genomic Profiling, Risk Stratification, and Post-Transformation Treatment — 2026
- Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology — Journal of the National Comprehensive Cancer Network · 2026
- Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC A Real-World Analysis Using a Nationwide Claims Database in Japan — 2026
- Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC A Real-World Analysis Using a Nationwide Claims Database in Japan — 2026
- Combined circulating tumor antigen model demonstrates additional prognostic value in first-line treatment of non-small cell lung cancer — 2026
- Radio-pathological correlation of organizing pneumonia (OP): a pictorial review — Br J Radiol · 2026
- Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study — Lung Cancer · 2025
- The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types — Nature Cancer · 2025
- Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 Trial — Journal of Thoracic Oncology · 2025
- Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer — Lung Cancer · 2025
- Pathological extranodal extension in head and neck cancer: A prognostic biomarker with therapeutic ramifications and diagnostic pitfalls — Pathology - Research and Practice · 2025
- Real-world outcomes of subsequent treatment strategies after durvalumab consolidation in stage III unresectable non-small cell lung cancer — 2025
- Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer — New England Journal of Medicine · 2025
- Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC — Clinical Cancer Research · 2025
- Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy — JAMA Oncology · 2025
- Risk factors and prognostic indicators for progressive fibrosing interstitial lung disease: a deep learning-based CT quantification approach — European Radiology · 2025
- Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer — 2024
- Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB–IIIB lung squamous cell carcinoma — Scientific Reports · 2024
- [[clinical-oncology/masse-2024-18f-fdg-petct-atypical-response-patterns-to|[18F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management proposal]] — European Journal of Nuclear Medicine and Molecular Imaging · 2024
- Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non–Small Cell Lung Cancer — 2024
- Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study — BMC Medicine · 2024
- Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology — Journal of the National Comprehensive Cancer Network · 2024
- Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis — JAMA Oncology · 2024
- Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer — 2024
- Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World) — The Journal of Thoracic and Cardiovascular Surgery · 2024
- Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets — Science Advances · 2023
- Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study — JTO Clinical and Research Reports · 2023
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non–Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer — Cancer · 2023
- Brief Report Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC A Post Hoc Subgroup Analysis From PACIFIC — 2023
- Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy PACIFIC-KR — 2023
- Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer — Frontiers in Oncology · 2023
- Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors — Science Advances · 2022
- De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer — 2022
- 2405-6308/© 2022 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. This is an open access article under the — 2022
- Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer — Journal of Clinical Oncology · 2022
- Five-Year Survival Outcomes From the PACIFIC Trial Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer — 2022
- Imaging the acute respiratory distress syndrome: past, present and future — Intensive Care Med · 2022
- Are radiomics features universally applicable to different organs? — Cancer Imaging · 2021
- Deep Learning to Estimate Biological Age From Chest Radiographs — JACC Cardiovascular Imaging · 2021
- Eradicating micrometastases with immune checkpoint blockade: Strike while the iron is hot — Cancer Cell · 2021
- The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition — Annals of Oncology · 2021
- Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker — Journal for Immunotherapy of Cancer · 2020
- PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma — Cancer Management and Research · 2020
- Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer — 2020
- Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial — 2020
- Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer — Scientific Reports · 2018
- Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer — New England Journal of Medicine · 2018
- Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden — 2018
- Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma — Journal of Thoracic Oncology · 2017
- Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma — npj Genomic Medicine · 2017
- Pulmonary Intravascular Lymphomatosis: Clinical, CT, and PET Findings, Correlation of CT and Pathologic Results, and Survival Outcome — Radiology · 2016
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer — Journal of Thoracic Oncology · 2016
- Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) — European Respiratory Journal · 2016
- Introduction to the Analysis of Survival Data in the Presence of Competing Risks — 2016
- Challenges of Guarantee-Time Bias — 2013
- Combined fluoroscopy-and CT-guided transthoracic needle biopsy using a C-arm cone-beam CT system: comparison with fluoroscopy-guided biopsy — Korean Journal of Radiology · 2011
- Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings — European Radiology · 2007
- Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression — 2007
- Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends — The Annals of Thoracic Surgery · 2006
- park-2026-quantitative-ct-imaging-in-progressive-pulmonary-fibrosis
Log-rank test (39편)
- Lee et al. - Lung Cancer 2026 - Surgical Attrition After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer: Real-World Experience and Predictors — Lung Cancer · 2026
- Interpretable multimodal deep learning for time-resolved survival prediction after hepatocellular carcinoma resection — npj Digital Medicine · 2026
- Genomic Profiling, Risk Stratification, and Post-Transformation Treatment — 2026
- Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology — Journal of the National Comprehensive Cancer Network · 2026
- Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study — Lung Cancer · 2025
- Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer — Lung Cancer · 2025
- Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer — New England Journal of Medicine · 2025
- Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC — Clinical Cancer Research · 2025
- Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy — JAMA Oncology · 2025
- Association between pathologic response and survival after neoadjuvant therapy in lung cancer — Nature Medicine · 2024
- Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer — 2024
- Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB–IIIB lung squamous cell carcinoma — Scientific Reports · 2024
- Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC — 2024
- [[clinical-oncology/masse-2024-18f-fdg-petct-atypical-response-patterns-to|[18F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management proposal]] — European Journal of Nuclear Medicine and Molecular Imaging · 2024
- Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study — BMC Medicine · 2024
- Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World) — The Journal of Thoracic and Cardiovascular Surgery · 2024
- Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets — Science Advances · 2023
- Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study — JTO Clinical and Research Reports · 2023
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non–Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer — Cancer · 2023
- Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial — The Annals of Thoracic Surgery · 2023
- Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer — New England Journal of Medicine · 2022
- Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer — Journal of Clinical Oncology · 2022
- Five-Year Survival Outcomes From the PACIFIC Trial Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer — 2022
- Are radiomics features universally applicable to different organs? — Cancer Imaging · 2021
- Deep Learning to Estimate Biological Age From Chest Radiographs — JACC Cardiovascular Imaging · 2021
- Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker — Journal for Immunotherapy of Cancer · 2020
- PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma — Cancer Management and Research · 2020
- Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer — 2020
- Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer — New England Journal of Medicine · 2018
- Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden — 2018
- Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma — Journal of Thoracic Oncology · 2017
- Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma — npj Genomic Medicine · 2017
- Pulmonary Intravascular Lymphomatosis: Clinical, CT, and PET Findings, Correlation of CT and Pathologic Results, and Survival Outcome — Radiology · 2016
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer — Journal of Thoracic Oncology · 2016
- Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) — European Respiratory Journal · 2016
- Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings — European Radiology · 2007
- park-2026-quantitative-ct-imaging-in-progressive-pulmonary-fibrosis
Competing risk analysis (7편)
- Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC A Real-World Analysis Using a Nationwide Claims Database in Japan — 2026
- Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC A Real-World Analysis Using a Nationwide Claims Database in Japan — 2026
- Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study — Lung Cancer · 2025
- Recurrence-Free Survival in Patients With Surgically Resected Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analysis — Chest · 2024
- Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial — The Annals of Thoracic Surgery · 2023
- Deep Learning to Estimate Biological Age From Chest Radiographs — JACC Cardiovascular Imaging · 2021
- Introduction to the Analysis of Survival Data in the Presence of Competing Risks — 2016
Landmark analysis (8편)
- Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study — Lung Cancer · 2025
- Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer — Lung Cancer · 2025
- Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer — 2024
- Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB–IIIB lung squamous cell carcinoma — Scientific Reports · 2024
- Derived neutrophil-to-lymphocyte ratio has the potential to predict safety and outcomes of durvalumab after chemoradiation in non-small cell lung cancer — 2024
- Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer — 2023
- 2405-6308/© 2022 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. This is an open access article under the — 2022
- Challenges of Guarantee-Time Bias — 2013
진단·예측 성능
ROC curve / AUC (37편)
- Multicentre performance and consistency of two deep learning models for malignancy probability estimation of incidental pulmonary nodules — 2026
- Interpretable multimodal deep learning for time-resolved survival prediction after hepatocellular carcinoma resection — npj Digital Medicine · 2026
- Genomic Profiling, Risk Stratification, and Post-Transformation Treatment — 2026
- Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer — Clinical Radiology · 2025
- Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC — Clinical Cancer Research · 2025
- MoE-Health: A Mixture of Experts Framework for Robust Multimodal Healthcare Prediction — arXiv preprint arXiv:2508.21793 · 2025
- The effect of feature normalization methods in radiomics — Insights Imaging · 2024
- Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study — Frontiers in Immunology · 2024
- Association between pathologic response and survival after neoadjuvant therapy in lung cancer — Nature Medicine · 2024
- Multimodal deep learning for integrating chest radiographs and clinical parameters: a case for transformers — Radiology · 2023
- Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study — JTO Clinical and Research Reports · 2023
- Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy PACIFIC-KR — 2023
- Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer — 2023
- Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer — Frontiers in Oncology · 2023
- Health system-scale language models are all-purpose prediction engines — Nature · 2023
- Making the Most Out of the Limited Context Length: Predictive Power Varies with Clinical Note Type and Note Section — arXiv preprint arXiv:2307.07051 · 2023
- Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors — Science Advances · 2022
- Dynamic (18) F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer — Thorac Cancer · 2022
- 2405-6308/© 2022 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. This is an open access article under the — 2022
- Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer — Journal of Clinical Oncology · 2022
- Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study — EBioMedicine · 2022
- Differential expression of PD‑L1 and PD‑L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non‑small cell lung cancer — Oncology Reports · 2022
- Air leak, barotrauma susceptibility, and imaging in acute respiratory distress syndrome novel application of an old tool — Intensive Care Med · 2022
- Development and validation of a deep learning algorithm detecting 10 common abnormalities on chest radiographs — European Respiratory Journal · 2021
- FeifeiZhao,MM;LiliChen,MM;MeiJi,MD;JunfeiZhu,MM;YongFang,MD;PeiruiChen,MM;PengWang,MM; — 2021
- Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker — Journal for Immunotherapy of Cancer · 2020
- Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: Correlation with immune profiles — PloS One · 2020
- PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma — Cancer Management and Research · 2020
- A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients — Journal of Critical Care · 2020
- The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy — Nature Communications · 2019
- Calibration: the Achilles heel of predictive analytics — BMC Medicine · 2019
- CD103+CD8+ Lymphocytes Characterize the Immune Infiltration in a Case With Pseudoprogression in Squamous NSCLC — Journal of Thoracic Oncology · 2018
- Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma — Journal of Thoracic Oncology · 2017
- Pembrolizumab for the treatment of non-small-cell lung cancer — New England Journal of Medicine · 2015
- The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets — PloS One · 2015
- Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints — BMC Medical Research Methodology · 2014
- Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends — The Annals of Thoracic Surgery · 2006
Sensitivity / Specificity (55편)
- Multicentre performance and consistency of two deep learning models for malignancy probability estimation of incidental pulmonary nodules — 2026
- Sublobar resection, stereotactic body radiotherapy, and thermal ablation for early-stage non-small cell lung cancer a systematic review and meta-analysis — Lung Cancer · 2026
- Lee et al. - Lung Cancer 2026 - Surgical Attrition After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer: Real-World Experience and Predictors — Lung Cancer · 2026
- Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC A Real-World Analysis Using a Nationwide Claims Database in Japan — 2026
- Radio-pathological correlation of organizing pneumonia (OP): a pictorial review — Br J Radiol · 2026
- Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine — Nature Reviews Clinical Oncology · 2025
- Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer — Clinical Radiology · 2025
- Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer — New England Journal of Medicine · 2025
- Risk factors and prognostic indicators for progressive fibrosing interstitial lung disease: a deep learning-based CT quantification approach — European Radiology · 2025
- The effect of feature normalization methods in radiomics — Insights Imaging · 2024
- Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study — Frontiers in Immunology · 2024
- Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial — Journal of Breast Cancer · 2024
- [[clinical-oncology/masse-2024-18f-fdg-petct-atypical-response-patterns-to|[18F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management proposal]] — European Journal of Nuclear Medicine and Molecular Imaging · 2024
- Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non–Small Cell Lung Cancer — 2024
- Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study — BMC Medicine · 2024
- Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis — JAMA Oncology · 2024
- Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-Analysis — JAMA Network Open · 2024
- Multimodal deep learning for integrating chest radiographs and clinical parameters: a case for transformers — Radiology · 2023
- Systematic review and meta-analysis of the prognostic impact of lymph node micrometastasis and isolated tumour cells in patients with stage I-IIIA non-small cell lung cancer — Histopathology · 2023
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non–Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer — Frontiers in Oncology · 2023
- Health system-scale language models are all-purpose prediction engines — Nature · 2023
- Making the Most Out of the Limited Context Length: Predictive Power Varies with Clinical Note Type and Note Section — arXiv preprint arXiv:2307.07051 · 2023
- De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer — 2022
- Dynamic (18) F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer — Thorac Cancer · 2022
- Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer — New England Journal of Medicine · 2022
- Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer — Acta Oncologica · 2022
- Air leak, barotrauma susceptibility, and imaging in acute respiratory distress syndrome novel application of an old tool — Intensive Care Med · 2022
- Algorithmic Approach to the Diagnosis of Organizing Pneumonia — CHEST · 2022
- A large language model for electronic health records — npj Digital Medicine · 2022
- Complications of Lung Transplantation: Update on Imaging Manifestations and Management — Radiology: Cardiothoracic Imaging · 2021
- Development and validation of a deep learning algorithm detecting 10 common abnormalities on chest radiographs — European Respiratory Journal · 2021
- Deep Learning to Estimate Biological Age From Chest Radiographs — JACC Cardiovascular Imaging · 2021
- Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-Analysis — Journal of Thoracic Oncology · 2021
- Tissue adequacy and safety of percutaneous transthoracic needle biopsy for molecular analysis in non-small cell lung cancer: a systematic review and meta-analysis — Korean Journal of Radiology · 2021
- Lesion-level heterogeneity of radiologic progression in patients treated with pembrolizumab — Annals of Oncology · 2021
- Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker — Journal for Immunotherapy of Cancer · 2020
- Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: Correlation with immune profiles — PloS One · 2020
- PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma — Cancer Management and Research · 2020
- A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients — Journal of Critical Care · 2020
- Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis — The Korean Journal of Internal Medicine · 2019
- Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma — Acta Oncologica · 2019
- Calibration: the Achilles heel of predictive analytics — BMC Medicine · 2019
- Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer — Scientific Reports · 2018
- Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma — npj Genomic Medicine · 2017
- The precision-recall plot is more informative than the ROC plot when evaluating binary classifiers on imbalanced datasets — PloS One · 2015
- Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints — BMC Medical Research Methodology · 2014
- Review of ongoing clinical trials in non-small-cell lung cancer: a status report for 2012 from the ClinicalTrials.gov Web site — Journal of Thoracic Oncology · 2013
- Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells — Cancer Research · 2012
- Combined fluoroscopy-and CT-guided transthoracic needle biopsy using a C-arm cone-beam CT system: comparison with fluoroscopy-guided biopsy — Korean Journal of Radiology · 2011
- An introduction to propensity score methods for reducing the effects of confounding in observational studies — Multivariate Behavioral Research · 2011
- From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors — Journal of Nuclear Medicine · 2009
- Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends — The Annals of Thoracic Surgery · 2006
- park-2026-quantitative-ct-imaging-in-progressive-pulmonary-fibrosis
C-index / Concordance (13편)
- Interpretable multimodal deep learning for time-resolved survival prediction after hepatocellular carcinoma resection — npj Digital Medicine · 2026
- Combined circulating tumor antigen model demonstrates additional prognostic value in first-line treatment of non-small cell lung cancer — 2026
- Risk factors and prognostic indicators for progressive fibrosing interstitial lung disease: a deep learning-based CT quantification approach — European Radiology · 2025
- Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB–IIIB lung squamous cell carcinoma — Scientific Reports · 2024
- Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study — JTO Clinical and Research Reports · 2023
- Investigation of radiomics based intra-patient inter-tumor heterogeneity and the impact of tumor subsampling strategies — Scientific Reports · 2022
- Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth? — Frontiers in Oncology · 2022
- Deep Learning to Estimate Biological Age From Chest Radiographs — JACC Cardiovascular Imaging · 2021
- Comparability of PD‐L1 immunohistochemistry assays for non‐small‐cell lung cancer a systematic review — 2020
- Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis — The Korean Journal of Internal Medicine · 2019
- Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer — Scientific Reports · 2018
- Gene expression markers of Tumor Infiltrating Leukocytes — Journal for Immunotherapy of Cancer · 2017
- park-2026-quantitative-ct-imaging-in-progressive-pulmonary-fibrosis
Calibration (11편)
- Interpretable multimodal deep learning for time-resolved survival prediction after hepatocellular carcinoma resection — npj Digital Medicine · 2026
- Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer — Clinical Radiology · 2025
- Risk factors and prognostic indicators for progressive fibrosing interstitial lung disease: a deep learning-based CT quantification approach — European Radiology · 2025
- MoE-Health: A Mixture of Experts Framework for Robust Multimodal Healthcare Prediction — arXiv preprint arXiv:2508.21793 · 2025
- The effect of feature normalization methods in radiomics — Insights Imaging · 2024
- Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study — Frontiers in Immunology · 2024
- Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer — Cancer · 2023
- Making the Most Out of the Limited Context Length: Predictive Power Varies with Clinical Note Type and Note Section — arXiv preprint arXiv:2307.07051 · 2023
- Calibration: the Achilles heel of predictive analytics — BMC Medicine · 2019
- Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma — Journal of Thoracic Oncology · 2017
- Mass estimates by computed tomography: physical density from CT numbers — American Journal of Roentgenology · 1984
회귀·교란 보정
Multivariable regression (62편)
- Lee et al. - Lung Cancer 2026 - Surgical Attrition After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer: Real-World Experience and Predictors — Lung Cancer · 2026
- Interpretable multimodal deep learning for time-resolved survival prediction after hepatocellular carcinoma resection — npj Digital Medicine · 2026
- Non–Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology — Journal of the National Comprehensive Cancer Network · 2026
- Durvalumab After Chemoradiotherapy for Locally Advanced NSCLC A Real-World Analysis Using a Nationwide Claims Database in Japan — 2026
- Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer — Clinical Radiology · 2025
- Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study — Lung Cancer · 2025
- Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer — Lung Cancer · 2025
- Pathological extranodal extension in head and neck cancer: A prognostic biomarker with therapeutic ramifications and diagnostic pitfalls — Pathology - Research and Practice · 2025
- Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC — Clinical Cancer Research · 2025
- Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy — JAMA Oncology · 2025
- Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): conventional and distribution-based immune profiling of the tumor microenvironment and peripheral circulation — Journal for ImmunoTherapy of Cancer · 2025
- Risk factors and prognostic indicators for progressive fibrosing interstitial lung disease: a deep learning-based CT quantification approach — European Radiology · 2025
- Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study — Frontiers in Immunology · 2024
- Association between pathologic response and survival after neoadjuvant therapy in lung cancer — Nature Medicine · 2024
- Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer — 2024
- Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial — Journal of Breast Cancer · 2024
- Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB–IIIB lung squamous cell carcinoma — Scientific Reports · 2024
- [[clinical-oncology/masse-2024-18f-fdg-petct-atypical-response-patterns-to|[18F]FDG-PET/CT atypical response patterns to immunotherapy in non-small cell lung cancer patients: long term prognosis assessment and clinical management proposal]] — European Journal of Nuclear Medicine and Molecular Imaging · 2024
- Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study — BMC Medicine · 2024
- Recurrence-Free Survival in Patients With Surgically Resected Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analysis — Chest · 2024
- Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World) — The Journal of Thoracic and Cardiovascular Surgery · 2024
- Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-Analysis — JAMA Network Open · 2024
- Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets — Science Advances · 2023
- Systematic review and meta-analysis of the prognostic impact of lymph node micrometastasis and isolated tumour cells in patients with stage I-IIIA non-small cell lung cancer — Histopathology · 2023
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non–Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer — Cancer · 2023
- Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer — 2023
- Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial — The Annals of Thoracic Surgery · 2023
- Making the Most Out of the Limited Context Length: Predictive Power Varies with Clinical Note Type and Note Section — arXiv preprint arXiv:2307.07051 · 2023
- Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors — Science Advances · 2022
- De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer — 2022
- Dynamic (18) F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer — Thorac Cancer · 2022
- Hallmarks of Cancer: New Dimensions — Cancer Discovery · 2022
- Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer — Acta Oncologica · 2022
- 2405-6308/© 2022 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. This is an open access article under the — 2022
- Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer — Journal of Clinical Oncology · 2022
- Five-Year Survival Outcomes From the PACIFIC Trial Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer — 2022
- Differential expression of PD‑L1 and PD‑L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non‑small cell lung cancer — Oncology Reports · 2022
- Algorithmic Approach to the Diagnosis of Organizing Pneumonia — CHEST · 2022
- Deep Learning to Estimate Biological Age From Chest Radiographs — JACC Cardiovascular Imaging · 2021
- consolidation therapy in patients with non-small cell lung cancer who — 2021
- The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition — Annals of Oncology · 2021
- Tissue adequacy and safety of percutaneous transthoracic needle biopsy for molecular analysis in non-small cell lung cancer: a systematic review and meta-analysis — Korean Journal of Radiology · 2021
- Lesion-level heterogeneity of radiologic progression in patients treated with pembrolizumab — Annals of Oncology · 2021
- Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker — Journal for Immunotherapy of Cancer · 2020
- Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: Correlation with immune profiles — PloS One · 2020
- PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma — Cancer Management and Research · 2020
- Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer — 2020
- Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis — The Korean Journal of Internal Medicine · 2019
- Tumor necrosis correlates with PD-L1 and PD-1 expression in lung adenocarcinoma — Acta Oncologica · 2019
- Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? — European Respiratory Journal · 2019
- The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy — Nature Communications · 2019
- Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer — Scientific Reports · 2018
- Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma — Journal of Thoracic Oncology · 2017
- Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma — npj Genomic Medicine · 2017
- Pulmonary Intravascular Lymphomatosis: Clinical, CT, and PET Findings, Correlation of CT and Pathologic Results, and Survival Outcome — Radiology · 2016
- Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) — European Respiratory Journal · 2016
- Combined fluoroscopy-and CT-guided transthoracic needle biopsy using a C-arm cone-beam CT system: comparison with fluoroscopy-guided biopsy — Korean Journal of Radiology · 2011
- Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression — 2007
- Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends — The Annals of Thoracic Surgery · 2006
- Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis — 1996
Logistic regression (31편)
- Autoimmune Features or Connective Tissue Disease Shows a — 2026
- Multicentre performance and consistency of two deep learning models for malignancy probability estimation of incidental pulmonary nodules — 2026
- Lee et al. - Lung Cancer 2026 - Surgical Attrition After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer: Real-World Experience and Predictors — Lung Cancer · 2026
- Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer — Clinical Radiology · 2025
- Risk factors and prognostic indicators for progressive fibrosing interstitial lung disease: a deep learning-based CT quantification approach — European Radiology · 2025
- The effect of feature normalization methods in radiomics — Insights Imaging · 2024
- Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study — Frontiers in Immunology · 2024
- Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB–IIIB lung squamous cell carcinoma — Scientific Reports · 2024
- Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study — BMC Medicine · 2024
- Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study — JTO Clinical and Research Reports · 2023
- Exploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer — 2023
- Dynamic (18) F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer — Thorac Cancer · 2022
- Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer — Acta Oncologica · 2022
- 2405-6308/© 2022 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. This is an open access article under the — 2022
- Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer — Journal of Clinical Oncology · 2022
- consolidation therapy in patients with non-small cell lung cancer who — 2021
- Lesion-level heterogeneity of radiologic progression in patients treated with pembrolizumab — Annals of Oncology · 2021
- Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: Correlation with immune profiles — PloS One · 2020
- PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma — Cancer Management and Research · 2020
- Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis — The Korean Journal of Internal Medicine · 2019
- Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? — European Respiratory Journal · 2019
- The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy — Nature Communications · 2019
- Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma — Journal of Thoracic Oncology · 2017
- Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) — European Respiratory Journal · 2016
- Adam: A method for stochastic optimization — arXiv preprint arXiv:1412.6980 · 2015
- Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints — BMC Medical Research Methodology · 2014
- Combined fluoroscopy-and CT-guided transthoracic needle biopsy using a C-arm cone-beam CT system: comparison with fluoroscopy-guided biopsy — Korean Journal of Radiology · 2011
- An introduction to propensity score methods for reducing the effects of confounding in observational studies — Multivariate Behavioral Research · 2011
- Relaxing the Rule of Ten Events per Variable in Logistic and Cox Regression — 2007
- Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends — The Annals of Thoracic Surgery · 2006
- Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis — 1996
Propensity score matching/weighting (12편)
- Sublobar resection, stereotactic body radiotherapy, and thermal ablation for early-stage non-small cell lung cancer a systematic review and meta-analysis — Lung Cancer · 2026
- Lee et al. - Lung Cancer 2026 - Surgical Attrition After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer: Real-World Experience and Predictors — Lung Cancer · 2026
- Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study — Lung Cancer · 2025
- Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer — Lung Cancer · 2025
- Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy — JAMA Oncology · 2025
- Efficacy of neoadjuvant immunochemotherapy and survival surrogate analysis of neoadjuvant treatment in IB–IIIB lung squamous cell carcinoma — Scientific Reports · 2024
- Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World) — The Journal of Thoracic and Cardiovascular Surgery · 2024
- Health system-scale language models are all-purpose prediction engines — Nature · 2023
- Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study — EBioMedicine · 2022
- A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients — Journal of Critical Care · 2020
- Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer — Scientific Reports · 2018
- An introduction to propensity score methods for reducing the effects of confounding in observational studies — Multivariate Behavioral Research · 2011
연구 설계
Subgroup analysis (32편)
- Radio-pathological correlation of organizing pneumonia (OP): a pictorial review — Br J Radiol · 2026
- Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study — Lung Cancer · 2025
- Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 Trial — Journal of Thoracic Oncology · 2025
- Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer — New England Journal of Medicine · 2025
- Association between pathologic response and survival after neoadjuvant therapy in lung cancer — Nature Medicine · 2024
- Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study — BMC Medicine · 2024
- Recurrence-Free Survival in Patients With Surgically Resected Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analysis — Chest · 2024
- Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis — JAMA Oncology · 2024
- Treatment patterns and clinical outcomes of patients with resectable non–small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World) — The Journal of Thoracic and Cardiovascular Surgery · 2024
- Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-Analysis — JAMA Network Open · 2024
- Systematic review and meta-analysis of the prognostic impact of lymph node micrometastasis and isolated tumour cells in patients with stage I-IIIA non-small cell lung cancer — Histopathology · 2023
- Association between diabetes mellitus and reduced efficacy of pembrolizumab in non-small cell lung cancer — Cancer · 2023
- Brief Report Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC A Post Hoc Subgroup Analysis From PACIFIC — 2023
- Chemo-Radio-Immunotherapy for NSCLC III ESRATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate — 2023
- Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors — Science Advances · 2022
- Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer — New England Journal of Medicine · 2022
- Quantifying the rate and predictors of occult lymph node involvement in patients with clinically node-negative non-small cell lung cancer — Acta Oncologica · 2022
- Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study — EBioMedicine · 2022
- Disclosure: Dr. Girard reports receiving research grants/support from — 2022
- Air leak, barotrauma susceptibility, and imaging in acute respiratory distress syndrome novel application of an old tool — Intensive Care Med · 2022
- Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review — Frontiers in Oncology · 2022
- Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-Analysis — Journal of Thoracic Oncology · 2021
- The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition — Annals of Oncology · 2021
- Tissue adequacy and safety of percutaneous transthoracic needle biopsy for molecular analysis in non-small cell lung cancer: a systematic review and meta-analysis — Korean Journal of Radiology · 2021
- Yu Wang, MD,*,# Tao Zhang, MD,*,# Yilin Huang, MS,y Wei Li, MD,* Jingjing Zhao, PhD,* Yin Yang, MD,* — 2021
- Lesion-level heterogeneity of radiologic progression in patients treated with pembrolizumab — Annals of Oncology · 2021
- PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma — Cancer Management and Research · 2020
- Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial — 2020
- A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients — Journal of Critical Care · 2020
- Pembrolizumab for the treatment of non-small-cell lung cancer — New England Journal of Medicine · 2015
- Combined fluoroscopy-and CT-guided transthoracic needle biopsy using a C-arm cone-beam CT system: comparison with fluoroscopy-guided biopsy — Korean Journal of Radiology · 2011
- From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors — Journal of Nuclear Medicine · 2009
Systematic review / Meta-analysis (28편)
- Sublobar resection, stereotactic body radiotherapy, and thermal ablation for early-stage non-small cell lung cancer a systematic review and meta-analysis — Lung Cancer · 2026
- Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine — Nature Reviews Clinical Oncology · 2025
- The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types — Nature Cancer · 2025
- Pathological extranodal extension in head and neck cancer: A prognostic biomarker with therapeutic ramifications and diagnostic pitfalls — Pathology - Research and Practice · 2025
- Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trials — Lung Cancer · 2025
- Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study — BMC Medicine · 2024
- Cancer-induced systemic pre-conditioning of distant organs: building a niche for metastatic cells — Nature Reviews Cancer · 2024
- Recurrence-Free Survival in Patients With Surgically Resected Non-Small Cell Lung Cancer: A Systematic Literature Review and Meta-Analysis — Chest · 2024
- Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis — JAMA Oncology · 2024
- Neoadjuvant-Adjuvant vs Neoadjuvant-Only PD-1 and PD-L1 Inhibitors for Patients With Resectable NSCLC: An Indirect Meta-Analysis — JAMA Network Open · 2024
- Systematic review and meta-analysis of the prognostic impact of lymph node micrometastasis and isolated tumour cells in patients with stage I-IIIA non-small cell lung cancer — Histopathology · 2023
- Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer — Frontiers in Oncology · 2023
- Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth? — Frontiers in Oncology · 2022
- Acute respiratory distress syndrome causes, pathophysiology, and phenotypes — The Lancet · 2022
- Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review — Frontiers in Oncology · 2022
- Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management — The Lancet · 2022
- ARDS Clinical Practice Guideline 2021 — Journal of Intensive Care · 2022
- Complications of Lung Transplantation: Update on Imaging Manifestations and Management — Radiology: Cardiothoracic Imaging · 2021
- Eradicating micrometastases with immune checkpoint blockade: Strike while the iron is hot — Cancer Cell · 2021
- Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-Analysis — Journal of Thoracic Oncology · 2021
- The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition — Annals of Oncology · 2021
- Tissue adequacy and safety of percutaneous transthoracic needle biopsy for molecular analysis in non-small cell lung cancer: a systematic review and meta-analysis — Korean Journal of Radiology · 2021
- Yu Wang, MD,*,# Tao Zhang, MD,*,# Yilin Huang, MS,y Wei Li, MD,* Jingjing Zhao, PhD,* Yin Yang, MD,* — 2021
- Lung Cancer in Korea — Journal of Thoracic Oncology · 2021
- Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-gamma signaling and tumor-infiltrating lymphocytes — Journal of Hematology & Oncology · 2021
- Comparability of PD‐L1 immunohistochemistry assays for non‐small‐cell lung cancer a systematic review — 2020
- Comparison of the morphologic criteria (RECIST) and metabolic criteria (EORTC and PERCIST) in tumor response assessments: a pooled analysis — The Korean Journal of Internal Medicine · 2019
- Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings — European Radiology · 2007
모델 검증
Cross-validation (17편)
- Lee et al. - Lung Cancer 2026 - Surgical Attrition After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer: Real-World Experience and Predictors — Lung Cancer · 2026
- Combined circulating tumor antigen model demonstrates additional prognostic value in first-line treatment of non-small cell lung cancer — 2026
- Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer — Clinical Radiology · 2025
- Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC — Clinical Cancer Research · 2025
- MoE-Health: A Mixture of Experts Framework for Robust Multimodal Healthcare Prediction — arXiv preprint arXiv:2508.21793 · 2025
- The effect of feature normalization methods in radiomics — Insights Imaging · 2024
- Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study — Frontiers in Immunology · 2024
- Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study — JTO Clinical and Research Reports · 2023
- Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors — Science Advances · 2022
- Dynamic (18) F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer — Thorac Cancer · 2022
- Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study — EBioMedicine · 2022
- Radiomics in Oncology: A Practical Guide — RadioGraphics · 2021
- Efficacy and Safety of First-Line Immunotherapy Combinations for Advanced NSCLC: A Systematic Review and Network Meta-Analysis — Journal of Thoracic Oncology · 2021
- The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition — Annals of Oncology · 2021
- Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer — Scientific Reports · 2018
- Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma — Journal of Thoracic Oncology · 2017
- Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints — BMC Medical Research Methodology · 2014
External validation (57편)
- Interpretable multimodal deep learning for time-resolved survival prediction after hepatocellular carcinoma resection — npj Digital Medicine · 2026
- Genomic Profiling, Risk Stratification, and Post-Transformation Treatment — 2026
- Radio-pathological correlation of organizing pneumonia (OP): a pictorial review — Br J Radiol · 2026
- Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer — Clinical Radiology · 2025
- Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 Trial — Journal of Thoracic Oncology · 2025
- Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer — Lung Cancer · 2025
- Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLC — Clinical Cancer Research · 2025
- Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): conventional and distribution-based immune profiling of the tumor microenvironment and peripheral circulation — Journal for ImmunoTherapy of Cancer · 2025
- MoE-Health: A Mixture of Experts Framework for Robust Multimodal Healthcare Prediction — arXiv preprint arXiv:2508.21793 · 2025
- Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations — The Lancet Oncology · 2024
- Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study — Frontiers in Immunology · 2024
- Association between pathologic response and survival after neoadjuvant therapy in lung cancer — Nature Medicine · 2024
- Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial — Journal of Breast Cancer · 2024
- Cancer-induced systemic pre-conditioning of distant organs: building a niche for metastatic cells — Nature Reviews Cancer · 2024
- Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology — Journal of the National Comprehensive Cancer Network · 2024
- Multimodal deep learning for integrating chest radiographs and clinical parameters: a case for transformers — Radiology · 2023
- Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets — Science Advances · 2023
- Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study — JTO Clinical and Research Reports · 2023
- Advances in efficacy prediction and monitoring of neoadjuvant immunotherapy for non-small cell lung cancer — Frontiers in Oncology · 2023
- Investigation of radiomics based intra-patient inter-tumor heterogeneity and the impact of tumor subsampling strategies — Scientific Reports · 2022
- Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors — Science Advances · 2022
- Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth? — Frontiers in Oncology · 2022
- Dynamic (18) F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer — Thorac Cancer · 2022
- Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer — New England Journal of Medicine · 2022
- Hallmarks of Cancer: New Dimensions — Cancer Discovery · 2022
- Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer — Journal of Clinical Oncology · 2022
- Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study — EBioMedicine · 2022
- Differential expression of PD‑L1 and PD‑L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non‑small cell lung cancer — Oncology Reports · 2022
- Air leak, barotrauma susceptibility, and imaging in acute respiratory distress syndrome novel application of an old tool — Intensive Care Med · 2022
- Acute respiratory distress syndrome causes, pathophysiology, and phenotypes — The Lancet · 2022
- Algorithmic Approach to the Diagnosis of Organizing Pneumonia — CHEST · 2022
- Imaging the acute respiratory distress syndrome: past, present and future — Intensive Care Med · 2022
- Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management — The Lancet · 2022
- A large language model for electronic health records — npj Digital Medicine · 2022
- Are radiomics features universally applicable to different organs? — Cancer Imaging · 2021
- Development and validation of a deep learning algorithm detecting 10 common abnormalities on chest radiographs — European Respiratory Journal · 2021
- Deep Learning to Estimate Biological Age From Chest Radiographs — JACC Cardiovascular Imaging · 2021
- Radiomics in Oncology: A Practical Guide — RadioGraphics · 2021
- The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition — Annals of Oncology · 2021
- Lung Cancer in Korea — Journal of Thoracic Oncology · 2021
- Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-gamma signaling and tumor-infiltrating lymphocytes — Journal of Hematology & Oncology · 2021
- Deciphering the tumor microenvironment through radiomics in non-small cell lung cancer: Correlation with immune profiles — PloS One · 2020
- A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients — Journal of Critical Care · 2020
- Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? — European Respiratory Journal · 2019
- The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy — Nature Communications · 2019
- Calibration: the Achilles heel of predictive analytics — BMC Medicine · 2019
- Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer — Scientific Reports · 2018
- The Eighth Edition AJCC Cancer Staging Manual Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging — 2017
- The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging — CA: A Cancer Journal for Clinicians · 2017
- Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma — npj Genomic Medicine · 2017
- Gene expression markers of Tumor Infiltrating Leukocytes — Journal for Immunotherapy of Cancer · 2017
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer — Journal of Thoracic Oncology · 2016
- Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) — European Respiratory Journal · 2016
- Pembrolizumab for the treatment of non-small-cell lung cancer — New England Journal of Medicine · 2015
- Review of ongoing clinical trials in non-small-cell lung cancer: a status report for 2012 from the ClinicalTrials.gov Web site — Journal of Thoracic Oncology · 2013
- Combined fluoroscopy-and CT-guided transthoracic needle biopsy using a C-arm cone-beam CT system: comparison with fluoroscopy-guided biopsy — Korean Journal of Radiology · 2011
- Mass estimates by computed tomography: physical density from CT numbers — American Journal of Roentgenology · 1984
일치도
Inter-observer agreement (kappa/ICC) (12편)
- Delta-radiomics features combined with haematological index predict pathological complete response after neoadjuvant immunochemotherapy in resectable non-small cell lung cancer — Clinical Radiology · 2025
- Pathological extranodal extension in head and neck cancer: A prognostic biomarker with therapeutic ramifications and diagnostic pitfalls — Pathology - Research and Practice · 2025
- Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations — The Lancet Oncology · 2024
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non-Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Radiologic Extranodal Extension of Metastatic Lymph Nodes in Patients With Non–Small Cell Lung Cancer: Prognostic Utility and Diagnostic Performance — American Journal of Roentgenology · 2023
- Are radiomics features universally applicable to different organs? — Cancer Imaging · 2021
- Radiomics in Oncology: A Practical Guide — RadioGraphics · 2021
- The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition — Annals of Oncology · 2021
- A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients — Journal of Critical Care · 2020
- Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma — Journal of Thoracic Oncology · 2017
- Pulmonary Intravascular Lymphomatosis: Clinical, CT, and PET Findings, Correlation of CT and Pathologic Results, and Survival Outcome — Radiology · 2016
- Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings — European Radiology · 2007